In 2023, the antiretroviral therapy coverage among male adults living with HIV in Malaysia stood at 55 units. Observing the years leading up to 2023, there is a noticeable positive trend in coverage, with year-on-year growth percentages of 2.08% and 2.04% for 2022 and 2023, respectively. Over the last five years, from 2018 to 2023, the CAGR was approximately 4.24%, signifying a steady increase. Forecasted data indicates this growth will continue, with an expected coverage of 66 units by 2028, showing a 15.79% total growth and a 5-year CAGR of 2.98%.
Future trends to watch for include continuous advancements in healthcare infrastructure, global health partnerships, and policy changes that could further influence the accessibility and affordability of antiretroviral therapy in Malaysia.
